Platelet Reactivity After TAVI: A Multicenter Pilot Study
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
A high platelet reactivity in patients with severe symptomatic Aortic Stenosis (AS) selected
for TAVI (Transcatheter aortic valve implantation) procedure has been demonstrated
previously, and the use of double antiaggregation therapy (DAPT) with Clopidogrel and
Acetylsalicylic acid (ASA) do not achieve consistent and adequate suppression of platelet
reactivity. The purpose of this study is evaluate the efficacy of ticagrelor alone versus
DAPT with clopidogrel and aspirin for the suppression of high platelet reactivity following
TAVI.
Phase:
Phase 4
Details
Lead Sponsor:
Andres Iñiguez Romo, MD, PhD Hospital de Meixoeiro